- Home
- OABI vs EMF Comparison
OABI vs EMF Comparison
Compare OABI & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- EMF
- Stock Information
- Founded
- OABI 2012
- EMF 1987
- Country
- OABI United States
- EMF United States
- Employees
- OABI 114
- EMF N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- EMF Finance/Investors Services
- Sector
- OABI Health Care
- EMF Finance
- Exchange
- OABI Nasdaq
- EMF Nasdaq
- Market Cap
- OABI 228.9M
- EMF 219.3M
- IPO Year
- OABI N/A
- EMF N/A
- Fundamental
- Price
- OABI $1.57
- EMF $15.65
- Analyst Decision
- OABI Strong Buy
- EMF
- Analyst Count
- OABI 3
- EMF 0
- Target Price
- OABI $6.67
- EMF N/A
- AVG Volume (30 Days)
- OABI 385.0K
- EMF 29.3K
- Earning Date
- OABI 08-06-2025
- EMF 01-01-0001
- Dividend Yield
- OABI N/A
- EMF 6.16%
- EPS Growth
- OABI N/A
- EMF N/A
- EPS
- OABI N/A
- EMF N/A
- Revenue
- OABI $23,027,000.00
- EMF N/A
- Revenue This Year
- OABI N/A
- EMF N/A
- Revenue Next Year
- OABI $44.99
- EMF N/A
- P/E Ratio
- OABI N/A
- EMF N/A
- Revenue Growth
- OABI 6.05
- EMF N/A
- 52 Week Low
- OABI $1.22
- EMF $10.58
- 52 Week High
- OABI $4.87
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- OABI 38.28
- EMF 64.06
- Support Level
- OABI $1.51
- EMF $15.08
- Resistance Level
- OABI $1.73
- EMF $15.69
- Average True Range (ATR)
- OABI 0.12
- EMF 0.28
- MACD
- OABI -0.01
- EMF -0.01
- Stochastic Oscillator
- OABI 11.32
- EMF 79.15
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.